Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2006, p. 2579-2580, Vol. 44, No. 7
0095-1137/06/$08.00+0 doi:10.1128/JCM.00818-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Center for Medical Mycology, University Hospitals of Cleveland/Case Western Reserve University, Cleveland, Ohio,1 Pfizer, Inc., New York, New York2
Received 17 April 2006/ Accepted 11 May 2006
In this study, the voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to fluconazole and griseofulvin. The MIC ranges of voriconazole, fluconazole, and griseofulvin, were 0.002 to 0.06 µg/ml, 0.25 to 32 µg/ml, and 0.125 to 2.0 µg/ml, respectively.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»